Virtual ICU Market Facilitates Remote Patient Monitoring to...

Virtual ICU Market Facilitates Remote Patient Monitoring to Stimulate Market Growth

Сообщение 2024-02-06 07:18:40

1Кб

The virtual intensive care unit (ICU) utilizes various technologies including digital stethoscope, high-resolution cameras, and wireless monitoring devices to enable remote monitoring of critical patients. Virtual ICU allows real-time monitoring of patients outside the physical ICU setting by connecting them to ICU experts through audiovisual technologies. This helps reduce length of hospital stay, avoid hospital readmissions, and lower healthcare costs. Virtual ICU provides timely treatment interventions for critical patients located in rural or remote areas with limited access to healthcare facilities.

Virtual ICU consists of technologies, equipment, and competencies that deliver continuous care to patients outside of a physical ICU. It facilitates remote monitoring of vital signs, lab results, medication management, and video consultation with ICU experts.

The global virtual ICU market is estimated to be valued at US$ 6 Mn in 2024 and is expected to exhibit a CAGR of 4.8% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.

Market Dynamics:

The increasing prevalence of chronic diseases and rising geriatric population prone to critical health conditions are major factors driving the growth of the virtual ICU market. As per the United Nations Department of Economic and Social Affairs, the proportion of world's population aged 65 years or over is projected to rise from 9.3% in 2020 to 16.0% in 2050. Further, growing need to expand healthcare access in remote areas with limited number of critical care beds and specialist doctors is fueling the adoption of virtual ICU systems. According to a report by Association of American Medical Colleges, the United States will face a shortage of between 46,000 to 121,000 physicians by 2032. Virtual ICU addresses this shortage by enabling care delivery from anywhere. In addition, rising healthcare costs have heightened focus on reducing hospital readmissions and days spent in ICUs. Virtual ICU aids in timely at-home recovery and prevents re-admissions, thereby curbing healthcare expenditure.

SWOT Analysis
Strength: The virtual ICU market size allows hospitals to remotely monitor critical care patients using telehealth technologies, reducing the risk of virus spread and saving lives during the COVID-19 pandemic. Virtual ICU solutions provide 24/7 access to ICU specialists from any location via video conferencing and telemetry monitoring. This enables small rural hospitals without intensive care units to offer advanced care.

Weakness: Deployment of virtual ICU solutions requires significant upfront investments in hardware, software, broadband connectivity and staff training. Initial setup costs may be prohibitive for some underfunded hospitals. There are also privacy and security concerns related to the transmission of sensitive patient health data via digital networks and platforms.

Opportunity: The COVID-19 outbreak has severely strained healthcare systems globally and highlighted the need for innovative virtual care models. Government agencies are actively working with hospitals to expand telehealth ICU programs using relief funding. There is a massive untapped customer base among major hospitals in developing Asian and African countries.

Threats: Interoperability issues between existing hospital IT systems and virtual ICU vendor platforms pose major integration challenges. Successful companies must also address concerns over data governance and liability in case of technology or network failures impacting clinical decisions. Established telemedicine firms may acquire smaller virtual ICU startups to enter this emerging space.

Key Takeaways
The global virtual ICU market is expected to witness high growth over the forecast period as it addresses the growing demand for telehealth and remote patient monitoring amid continued uncertainty over coronavirus mutations and future pandemics. The global virtual ICU market is estimated to be valued at US$ 6 Mn in 2024 and is expected to exhibit a CAGR of 4.8% over the forecast period 2024 to 2031.

Regional analysis: North America currently dominates the virtual ICU market due to widespread technology adoption, advanced healthcare infrastructure and supportive regulatory framework for telehealth. However, Asia Pacific is projected to be the fastest growing regional market. Countries like India, China, and Japan are making massive investments to modernize their hospital networks which will drive growth of virtual care delivery models.

Key players: Key players operating in the virtual ICU market are Emergent Biosolutions Inc., SIGA Technologies Inc., Bavarian Nordic A/S, Elusys Therapeutics Inc., Ichor Medical Systems Inc., Amgen Inc., Cleveland BioLabs Inc., Dynavax Technologies Corporation, Alnylam Pharmaceuticals Inc., and XOMA Corporation. Their strategic collaborations with major hospital chains and health systems will be critical for commercial roll-out of integrated virtual ICU solutions at scale over the forecast period.